Epigral Ltd
NSE:EPIGRAL

Watchlist Manager
Epigral Ltd Logo
Epigral Ltd
NSE:EPIGRAL
Watchlist
Price: 1 128.3 INR 2.73%
Market Cap: ₹48.7B

Balance Sheet

Balance Sheet Decomposition
Epigral Ltd

Balance Sheet
Epigral Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
7
251
151
68
234
Cash
4
0
0
0
0
Cash Equivalents
3
251
151
68
234
Short-Term Investments
0
4
122
0
766
Total Receivables
1 239
2 593
1 801
2 196
2 731
Accounts Receivables
1 238
2 563
1 663
1 788
2 323
Other Receivables
1
30
138
408
408
Inventory
540
1 597
2 173
2 721
4 003
Other Current Assets
28
25
70
34
18
Total Current Assets
1 813
4 469
4 195
5 019
7 752
PP&E Net
11 965
16 287
19 370
22 275
22 832
PP&E Gross
11 965
16 287
19 370
22 275
22 832
Accumulated Depreciation
3 188
4 009
5 066
6 269
6 996
Intangible Assets
317
284
252
220
187
Note Receivable
25
114
226
138
465
Long-Term Investments
18
3
210
210
216
Other Long-Term Assets
350
80
70
81
73
Total Assets
14 488
N/A
21 237
+47%
24 322
+15%
27 943
+15%
31 524
+13%
Liabilities
Accounts Payable
730
881
1 102
1 653
1 857
Accrued Liabilities
33
184
193
138
50
Short-Term Debt
750
801
917
2 210
495
Current Portion of Long-Term Debt
1 235
1 422
2 411
1 959
907
Other Current Liabilities
1 137
2 034
1 855
1 836
1 619
Total Current Liabilities
3 887
5 323
6 477
7 796
4 927
Long-Term Debt
3 435
7 708
5 460
5 471
4 523
Deferred Income Tax
308
918
1 667
2 087
2 937
Other Liabilities
16
29
27
49
92
Total Liabilities
7 646
N/A
13 977
+83%
13 631
-2%
15 402
+13%
12 479
-19%
Equity
Common Stock
416
416
416
416
431
Retained Earnings
0
6 844
10 276
12 126
18 614
Other Equity
6 426
0
10 276
12 126
0
Total Equity
6 841
N/A
7 260
+6%
10 691
+47%
12 541
+17%
19 045
+52%
Total Liabilities & Equity
14 488
N/A
21 237
+47%
24 322
+15%
27 943
+15%
31 524
+13%
Shares Outstanding
Common Shares Outstanding
42
42
42
42
43
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett